NASA Logo

NTRS

NTRS - NASA Technical Reports Server

Back to Results
Monitoring Immune System Function and Reactivation of Latent Viruses in the Artificial Gravity Pilot StudyNumerous studies have indicated that dysregulation of the immune system occurs during or after spaceflight. Using 21 day -6 degrees head-down tilt bed rest as a spaceflight analog, this study describes the effects of artificial gravity (AG) as a daily countermeasure on immunity, stress and reactivation of clinically important latent herpes viruses. The specific aims were to evaluate psychological and physiological stress, to determine the status of the immune system, and to quantify reactivation of latent herpes viruses. Blood, saliva, and urine samples were collected from each participating subject at different times throughout the study. An immune assessment was performed on all treatment and control subjects that consisted of a comprehensive peripheral immunophenotype analysis, intracellular cytokine profiles and a measurement of T cell function. The treatment group displayed no differences throughout the course of the study with regards to peripheral leukocyte distribution, cytokine production or T cell function. Shedding of Epstein barr virus (EBV), Cytomegalovirus (CMV), and Varicella zoster virus (VZV) was quantified by real time PCR in saliva and urine samples, respectively. There was no significant difference in CMV DNA in the treatment group as compared to the control group. EBV and VZV on the other hand showed a mild reactivation during the study. There were no significant differences in cortisol between the control and treatment groups. In addition, no significant differences between antiviral antibody titers (EBV-VCA, -EA, -EBNA, CMV) or tetramer-positive (EBV, CMV) were found between the two groups. EBV DNA copies in blood were typically undetectable but never exceeded 1,500 copies per 106 PBMCs. Overall, these data indicate that the artificial gravity countermeasure and the 21 day head-down tilt bed rest regimen had no observable adverse effect on immune function.
Document ID
20070035022
Acquisition Source
Johnson Space Center
Document Type
Conference Paper
Authors
Mehta, Satish K.
(Enterprise Advisory Services, Inc. Houston, TX, United States)
Crucian, Brian
(Wyle Labs., Inc. Houston, TX, United States)
Pierson, Duane L.
(NASA Johnson Space Center Houston, TX, United States)
Sams, Clarence
(NASA Johnson Space Center Houston, TX, United States)
Stowe, Raymond P.
(Microgen Labs. La Marque, TX, United States)
Date Acquired
August 24, 2013
Publication Date
January 1, 2007
Subject Category
Aerospace Medicine
Distribution Limits
Public
Copyright
Public Use Permitted.
No Preview Available